Stem Cells have a history of controversy for a long time. It was first used about thirty years ago and some people had unbelievable success with it while others had no success. To complicate the issues, many companies started to advertise that they are doing stem cell. FDA had not regulated the market yet, so some people were calling “stem cells” the procedure of drawing blood, spin it and re-inject the white portion in the affected area. Some companies pretended to have thousands of living cells in the tissues while others were more modest…
By the end of last year, few companies emerged that separated them from the rest. One of those companies was Tissue Tech. They did spend about 14 years to identify which molecule in the umbilical cord or placenta is responsible for regeneration of the tissue.
Over 40 patents later, 14 years of research the molecule finally emerged. It is HC-Ha_PTX13. It is a specialized molecule present in the umbilical cord, very little in the placenta, during ovulation cycle- in the preparation for the new life- and in a very small amount in the mesenchymal cells in adults.
They had tried the molecule first on animal models. To try something that does not leave room for biases, they started with spina bifida stage 3 (where the spinal cord is completely exposed, try to repair the defect and added the product as a nerve sheet to promote regeneration and decrease inflammation and pain. Fast forward, now they do have the third approval from the NIH (National Institute of Health) for the next 100 human cases as the first and the next three human cases that were performed had zero neurological deficit.
We are using the product form Tissue Teck in our clinic. This was the one I did use to inject my own knee. This is the one I used for articular cartilage defects in ankle, knee, & damaged tendons.
